The National Survey of Substance Use and Mental Health Services (N-SUMHSS) is a voluntary, annual survey that collects data from all active substance use and mental health treatment facilities across the United States, its territories, and...
People with opioid use disorder (OUD) are frequently in contact with the court system and have markedly higher rates of fatal opioid overdose. Opioid intervention courts (OIC) were developed to address increasing rates of opioid...
Read key findings from the 2022 National Survey on Drug Use and Health (NSDUH). This report highlights 2022 statistics on substance use, mental health, and treatment in the United States. These national indicators are measured...
The Many Paths to Wellness: Explore Chapter 5 in "Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health," which defines the concept of recovery from substance use disorders and reviews methods used by...
This Sharing Session was part one of a two-part series focusing on helping HEAL addiction researchers use language, imagery, and storytelling in respectful ways that engage all stakeholders.
During their day-to-day work, first responders such as law enforcement officers, firefighters, and emergency medical services (EMS) personnel often encounter people who use drugs (PWUD), including alcohol, opioids, stimulants, and...
In this research, the authors explored how lesbian, gay, bisexual, transgender, and queer (LGBTQ) young adults with problematic substance use made sense of their substance use in relation to their LGBTQ identities.
The authors interviewed...
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
The crisis of opioid use puts a strain on resources in the United States and worldwide. There are 3 US Food and Drug Administration–approved medications for treatment of opioid use disorder: methadone, buprenorphine...
As attitudes toward cannabis, its legal status, and patterns of use continue to evolve, the landscape surrounding this substance is in a constant state of flux. Against this backdrop, this review aims to provide an up-to-date...
The impacts of Adverse Childhood Experiences (ACEs) on behavioral, mental, and physical health have been extensively investigated. As such, it is paramount to synthesize their quantified effects, especially within...
People with mental illness and/or SUD are disproportionally affected by HIV. They may participate in behaviours that increase risk for contracting and transmitting HIV, such as sharing injection drug equipment or...
The COVID-19 emergency has tested the public health, medical, and public safety infrastructure of the United States (U.S.) in unprecedented ways. As the focal point for public health in their communities, local health...
Importance Substance use disorders are associated with high rates of emergency department (ED) use and challenges engaging with primary care services.
Objective To examine 5-year health care engagement and utilization outcomes...
NADCP is partnering with the American Society of Addiction Medicine (ASAM) to offer a new training for medical providers working with participants in drug treatment courts. This training will help medical providers learn how to successfully...
